Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 89.70
-0.70 (-0.77%)
Jul 3, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 496.24 million as of July 2, 2026. Its market cap has decreased by -11.29% in one year.
Market Cap
496.24M
Enterprise Value
435.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
89.70
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 496.24M, an increase of 331.37%. That is a compound annual growth rate of 36.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 496.24M | 29.86% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 475.23M |
| Syn2bio | 427.90M |
| Ryvu Therapeutics | 350.50M |
| BIOTON | 340.88M |
| Synthaverse | 217.08M |
| Molecure | 124.44M |
| Mabion | 117.66M |
| Poltreg | 108.86M |